Literature DB >> 2026876

IL-8 in septic shock, endotoxemia, and after IL-1 administration.

K J Van Zee1, L E DeForge, E Fischer, M A Marano, J S Kenney, D G Remick, S F Lowry, L L Moldawer.   

Abstract

Much effort has been directed toward elucidating the host response to sepsis and inflammation, resulting in the definition of a cascade of endogenous mediators that direct metabolic and immunological responses. Here we report that IL-8, a novel cytokine produced by a variety of cells in vitro in response to stimulation with bacterial LPS and the proinflammatory cytokines, appears in the circulation of primates in vivo during septic shock, sublethal endotoxemia, and after the administration of IL-1 alpha. The magnitude of the IL-8 response correlates with the severity of the insult, and levels of IL-8 peak relatively late, after those of TNF-alpha and IL-1 beta, and simultaneously with those of IL-6. IL-8 has been primarily defined as a selective activator and chemoattractant of neutrophils, and we demonstrate that after LPS or IL-1 alpha infusion, circulating neutrophil numbers rapidly recover from an initial neutropenia while IL-8 concentrations are maximal, supporting the hypothesis that IL-8 influences circulating leukocyte populations in vivo. We conclude that IL-8 is another participant in the cytokine cascade elicited by sepsis and inflammation and, as such, may play a significant role in host defense and disease.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2026876

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  71 in total

1.  Cytokine release and dynamics of leukocyte populations after CD3/TCR monoclonal antibody treatment.

Authors:  G J Zlabinger; K M Stuhlmeier; R Eher; S Schmaldienst; R Klauser; A Vychytil; B Watschinger; O Traindl; J Kovarik; E Pohanka
Journal:  J Clin Immunol       Date:  1992-05       Impact factor: 8.317

2.  Urinalysis for interleukin-8 in the non-invasive diagnosis of acute and chronic inflammatory diseases.

Authors:  A S Taha; V Grant; R W Kelly
Journal:  Postgrad Med J       Date:  2003-03       Impact factor: 2.401

3.  Elevation of platelet activating factor, inflammatory cytokines, and coagulation factors in the internal jugular vein of patients with subarachnoid hemorrhage.

Authors:  Y Hirashima; S Nakamura; S Endo; N Kuwayama; Y Naruse; A Takaku
Journal:  Neurochem Res       Date:  1997-10       Impact factor: 3.996

4.  Neutrophil attractant protein-1-immunoglobulin G immune complexes and free anti-NAP-1 antibody in normal human serum.

Authors:  I Sylvester; T Yoshimura; M Sticherling; J M Schröder; M Ceska; P Peichl; E J Leonard
Journal:  J Clin Invest       Date:  1992-08       Impact factor: 14.808

Review 5.  Status of immune mediators in complex regional pain syndrome type I.

Authors:  Christian Schinkel; Martin H Kirschner
Journal:  Curr Pain Headache Rep       Date:  2008-06

6.  Changes in neutrophil CD11b/CD18 and L-selectin expression and release of interleukin 8 and elastase in paediatric cardiopulmonary bypass.

Authors:  A Finn; N Moat; N Rebuck; N Klein; S Strobel; M Elliott
Journal:  Agents Actions       Date:  1993

7.  Diminished cord blood lymphocyte L-selectin expression in neonatal bacterial infection.

Authors:  C Bührer; U Luxenburger; B Metze; E Kattner; G Henze; J W Dudenhausen; M Obladen
Journal:  Eur J Pediatr       Date:  1993-06       Impact factor: 3.183

Review 8.  Modulating LPS signal transduction at the LPS receptor complex with synthetic Lipid A analogues.

Authors:  Aileen F B White; Alexei V Demchenko
Journal:  Adv Carbohydr Chem Biochem       Date:  2014       Impact factor: 12.200

9.  Tolerance to endotoxin-induced expression of the interleukin-1 beta gene in blood neutrophils of humans with the sepsis syndrome.

Authors:  C E McCall; L M Grosso-Wilmoth; K LaRue; R N Guzman; S L Cousart
Journal:  J Clin Invest       Date:  1993-03       Impact factor: 14.808

10.  High levels of interleukin-8 in the blood and alveolar spaces of patients with pneumonia and adult respiratory distress syndrome.

Authors:  S Chollet-Martin; P Montravers; C Gibert; C Elbim; J M Desmonts; J Y Fagon; M A Gougerot-Pocidalo
Journal:  Infect Immun       Date:  1993-11       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.